The American Hospital Association has called on federal regulators to intervene after Eli Lilly sent warning letters to 340B hospitals threatening to cut off discounted drug pricing unless they submit ...

Hospitals and clinics told regulators that switching to rebates in the 340B drug discount program would impose costs that ...

The American Hospital Association (AHA) writes to alert you to the latest development in connection with the growing number ...

When South Dakota’s Rep. Dusty Johnson (R-SD) speaks about expanding the federal 340B Drug Pricing Program, he does so with ...

In February 2026, the Department of Justice filed amicus briefs supporting pharmaceutical manufacturers, asserting that Rhode ...

President Donald Trump has repeatedly vowed to “cut waste, fraud and abuse everywhere that we can find it.” Congressional ...

The Trump administration is taking a targeted approach to reform a federal program that has long failed the patients and communities it was created to serve. Congress should allow that to move forward ...

New platform unifies data, automates workflows, and delivers predictive intelligence to help pharmacists and other health care providers maximize 340B performance, improve and accelerate patient ...

The Health Resources and Services Administration should abandon its consideration of a 340B rebate model pilot program ...

Michigan's 340B Drug Pricing Program, meant to help vulnerable patients, is being misused by hospitals, impacting care access.

A new analysis from healthcare consulting firm Trilliant Health contains some grim news for people concerned about the plight ...

Ravin Consultants announced today a leadership evolution that reflects the strength of its foundation and its long-term vision for the future of the 340B program. This press release features ...